2022
Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: Differences in methods and reference values
Arends S, Drenthen J, van den Bergh P, Franssen H, Hadden R, Islam B, Kuwabara S, Reisin R, Shahrizaila N, Amino H, Antonini G, Attarian S, Balducci C, Barroso F, Bertorini T, Binda D, Brannagan T, Buermann J, Casasnovas C, Cavaletti G, Chao C, Dimachkie M, Fulgenzi E, Galassi G, Gutiérrez G, Harbo T, Hartung H, Hsieh S, Kiers L, Lehmann H, Manganelli F, Marfia G, Mataluni G, Pardo J, Péréon Y, Rajabally Y, Santoro L, Sekiguchi Y, Stein B, Stettner M, Uncini A, Verboon C, Verhamme C, Vytopil M, Waheed W, Wang M, Zivkovic S, Jacobs B, Cornblath D, consortium T, Addington J, Ajroud-Driss S, Andersen H, Antonini G, Attarian S, Badrising U, Balloy G, Barroso F, Bateman K, Bella I, Benedetti L, van den Bergh P, Bertorini T, Bhavaraju-Sanka R, Bianco M, Brannagan T, Briani C, Buerrmann, Busby M, Butterworth S, Casasnovas C, Cavaletti G, Chao C, Chavada G, Chen S, Claeys K, Conti M, Cornblath D, Cosgrove J, Dalakas M, van Damme P, Dardiotis E, Davidson A, Derejko M, van Dijk G, Dimachkie M, van Doorn P, de la Cour C, Echaniz-Laguna A, Eftimov F, Faber C, Fazio R, Feasby T, Fokke C, Fujioka T, Fulgenzi E, Galassi G, Garcia-Sobrino T, Garssen M, Gijsbers C, Gilchrist J, Gilhuis H, Goldstein J, Gorson K, Goyal N, Granit V, Grisanti S, Gutiérrez-Gutiérrez, Gutmann L, Hadden R, Harbo T, Hartung H, Holbech J, Holt J, Hsieh S, Htut M, Hughes R, Illa I, Islam B, Islam Z, Jacobs B, Fehmi J, Jellema K, Pascual I, Kaida K, Karafiath S, Katzberg H, Khoshnoodi M, Kiers L, Kimpinski K, Kleyweg R, Kokubun N, Kolb N, van Koningsveld R, van der Kooi A, Kramers J, Kuitwaard K, Kusunoki S, Kuwabara S, Kwan J, Ladha S, Lassen L, Lawson V, Lehmann H, Pan E, Lunn M, Manji H, Marfia G, Infante C, Martin-Aguilar L, Hernandez E, Mataluni G, Mattiazi M, McDermott C, Meekins G, Miller J, Mohammad Q, Monges M, de la Tassa G, Nascimbene C, Navacerrada-Barrero F, Nobile-Orazio E, Nowak R, Orizaola P, Osei-Bonsu M, Pardal A, Pardo J, Pascuzzi R, Péréon Y, Pulley M, Querol L, Reddel S, van der Ree T, Reisin R, Rinaldi S, Roberts R, Rojas-Marcos I, Rudnicki, Sachs G, Samijn J, Santoro L, Schenone A, Tous M, Shahrizaila N, Sheikh K, Silvestri N, Sindrup S, Sommer C, Stein B, Song Y, Stino A, Tankisi H, Tannemaat M, Twydell P, Vélez-Santamaria P, Varrato J, Vermeij F, Visser L, Vytopil M, Waheed W, Walgaard C, Wang Y, Willison H, Wirtz P, Yamagishi Y, Zhou L, Zivkovic S. Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: Differences in methods and reference values. Clinical Neurophysiology 2022, 138: 231-240. PMID: 35078730, DOI: 10.1016/j.clinph.2021.12.014.Peer-Reviewed Original ResearchMeSH KeywordsElectrodiagnosisGuillain-Barre SyndromeHumansNeural ConductionOutcome Assessment, Health CareReference Values
2020
Effects of mexiletine on hyperexcitability in sporadic amyotrophic lateral sclerosis: Preliminary findings from a small phase II randomized controlled trial
Weiss M, Macklin E, McIlduff C, Vucic S, Wainger B, Kiernan M, Goutman S, Goyal N, Rutkove S, Ladha S, Chen I, Harms M, Brannagan T, Lacomis D, Zivkovic S, Ma M, Wang L, Simmons Z, Rivner M, Shefner J, Cudkowicz M, Atassi N, Group F. Effects of mexiletine on hyperexcitability in sporadic amyotrophic lateral sclerosis: Preliminary findings from a small phase II randomized controlled trial. Muscle & Nerve 2020, 63: 371-383. PMID: 33340120, PMCID: PMC8513796, DOI: 10.1002/mus.27146.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAmyotrophic Lateral SclerosisAxonsCortical ExcitabilityDouble-Blind MethodElectrodiagnosisElectromyographyEvoked Potentials, MotorFemaleHumansMaleMedian NerveMexiletineMiddle AgedNeural ConductionPreliminary DataTranscranial Magnetic StimulationVoltage-Gated Sodium Channel BlockersConceptsEffects of mexiletineResting motor thresholdSporadic amyotrophic lateral sclerosisRandomized controlled trialsAxonal hyperexcitabilityAmyotrophic lateral sclerosisRandomized to placeboAxonal excitability studiesCompared to placeboPhase II randomized controlled trialSecondary outcome measuresTranscranial magnetic stimulationPrimary endpointLateral sclerosisAxonal excitabilityHalf-timeTreated subjectsMexiletineReduction of motorControlled trialsHyperexcitabilityALS subjectsAlternative causesMagnetic stimulationOutcome measuresQuality measures in electrodiagnosis: Carpal tunnel syndrome—An AANEM Quality Measure Set
Zivkovic S, Gruener G, Arnold M, Winter C, Nuckols T, Narayanaswami P, Medicine A. Quality measures in electrodiagnosis: Carpal tunnel syndrome—An AANEM Quality Measure Set. Muscle & Nerve 2020, 61: 460-465. PMID: 31950523, DOI: 10.1002/mus.26810.Peer-Reviewed Original ResearchMeSH KeywordsCarpal Tunnel SyndromeElectrodiagnosisHumansMedian NerveNeural ConductionQuality Indicators, Health CareQuality of Health CareConceptsQuality measuresEvaluation of careImprove care of patientsQuality improvement committeeWork-related disabilityValue-based systemCare of patientsGoal of improving outcomesCarpal tunnel syndromeUnited States transitionsPostimplementation assessmentImprove careAssessment of outcomesNeuromuscular conditionsTunnel syndromeMedian neuropathyAmerican AssociationEDX testingElectrodiagnosisOutcomesPostimplementationCareHealthcareQualityDisability